Virtuoso Surgical’s robotic system received Breakthrough Device Designation from the FDA in September 2025. The designation is given to medical devices that may offer more effective diagnosis or treatment of life-threatening or irreversibly debilitating diseases.
The robotic system became the first device in a new FDA category for electromechanical surgical systems used in endoluminal procedures, in which instruments are inserted into the body through an endoscope.